Network-based inference of protein activity helps functionalize the genetic landscape of cancer
暂无分享,去创建一个
Mariano J. Alvarez | A. Califano | M. Alvarez | Alexander Lachmann | F. Giorgi | Yao Shen | B. B. Ding | B. H. Ye | B. Ye | B. Ye
[1] Ash A. Alizadeh,et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.
[2] M. Ashburner,et al. Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.
[3] I. Weinstein. Addiction to Oncogenes--the Achilles Heal of Cancer , 2002, Science.
[4] D. Pe’er,et al. Module networks: identifying regulatory modules and their condition-specific regulators from gene expression data , 2003, Nature Genetics.
[5] John Quackenbush,et al. Open source software for the analysis of microarray data. , 2003, BioTechniques.
[6] Andrea Califano,et al. Transcriptional analysis of the B cell germinal center reaction , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[7] Benjamin M. Bolstad,et al. affy - analysis of Affymetrix GeneChip data at the probe level , 2004, Bioinform..
[8] Seon-Young Kim,et al. PAGE: Parametric Analysis of Gene Set Enrichment , 2005, BMC Bioinform..
[9] Adam A. Margolin,et al. Reverse engineering of regulatory networks in human B cells , 2005, Nature Genetics.
[10] P. Park,et al. Discovering statistically significant pathways in expression profiling studies. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[11] T. Barrette,et al. Mining for regulatory programs in the cancer transcriptome , 2005, Nature Genetics.
[12] Daniel J. Vis,et al. T-profiler: scoring the activity of predefined groups of genes using gene expression data , 2005, Nucleic Acids Res..
[13] J. Collins,et al. Chemogenomic profiling on a genome-wide scale using reverse-engineered gene networks , 2005, Nature Biotechnology.
[14] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[15] A. Levine,et al. The p53 pathway: positive and negative feedback loops , 2005, Oncogene.
[16] Paul A Clemons,et al. The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease , 2006, Science.
[17] Alexandre V. Morozov,et al. Statistical mechanical modeling of genome-wide transcription factor occupancy data by MatrixREDUCE , 2006, ISMB.
[18] Joe W Gray,et al. Beta1 integrin inhibitory antibody induces apoptosis of breast cancer cells, inhibits growth, and distinguishes malignant from normal phenotype in three dimensional cultures and in vivo. , 2006, Cancer research.
[19] Chris Wiggins,et al. ARACNE: An Algorithm for the Reconstruction of Gene Regulatory Networks in a Mammalian Cellular Context , 2004, BMC Bioinformatics.
[20] Thomas D. Wu,et al. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. , 2006, Cancer cell.
[21] Zhen Jiang,et al. Bioconductor Project Bioconductor Project Working Papers Year Paper Extensions to Gene Set Enrichment , 2013 .
[22] Qi Liu,et al. Improving gene set analysis of microarray data by SAM-GS , 2007, BMC Bioinformatics.
[23] A. Kundaje,et al. Learning Regulatory Programs That Accurately Predict Differential Expression with MEDUSA , 2007, Annals of the New York Academy of Sciences.
[24] R. Tothill,et al. Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome , 2008, Clinical Cancer Research.
[25] Xiang-Jun Lu,et al. Inferring Condition-Specific Modulation of Transcription Factor Activity in Yeast through Regulon-Based Analysis of Genomewide Expression , 2008, PloS one.
[26] Annarita D'Addabbo,et al. Comparative study of gene set enrichment methods , 2009, BMC Bioinformatics.
[27] G. Cattoretti,et al. Constitutively activated STAT3 promotes cell proliferation and survival in the activated B-cell subtype of diffuse large B-cell lymphomas. , 2007, Blood.
[28] Doheon Lee,et al. Inferring Pathway Activity toward Precise Disease Classification , 2008, PLoS Comput. Biol..
[29] Ji Luo,et al. Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction , 2009, Cell.
[30] R. Dalla‐Favera,et al. Mutations of multiple genes cause deregulation of NF-κB in diffuse large B-cell lymphoma , 2009, Nature.
[31] Mariano J. Alvarez,et al. Genome-wide Identification of Post-translational Modulators of Transcription Factor Activity in Human B-Cells , 2009, Nature Biotechnology.
[32] D. Hunter,et al. mixtools: An R Package for Analyzing Mixture Models , 2009 .
[33] David R. Hunter,et al. mixtools: An R Package for Analyzing Mixture Models , 2009 .
[34] Gavin MacBeath,et al. Dissecting protein function and signaling using protein microarrays. , 2009, Current opinion in chemical biology.
[35] Mariano J. Alvarez,et al. Correlating measurements across samples improves accuracy of large-scale expression profile experiments , 2009, Genome Biology.
[36] Kai Wang,et al. Dissecting the Interface Between Signaling and Transcriptional Regulation in Human B Cells , 2008, Pacific Symposium on Biocomputing.
[37] Jeffrey M. Rosen,et al. Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features , 2009, Proceedings of the National Academy of Sciences.
[38] Andrea Califano,et al. Integrated biochemical and computational approach identifies BCL6 direct target genes controlling multiple pathways in normal germinal center B cells. , 2008, Blood.
[39] David Haussler,et al. Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM , 2010, Bioinform..
[40] J. Uhm,et al. The transcriptional network for mesenchymal transformation of brain tumours , 2010 .
[41] M. Gönen,et al. Cellular and genetic diversity in the progression of in situ human breast carcinomas to an invasive phenotype. , 2010, The Journal of clinical investigation.
[42] W. Huber,et al. which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. MAnorm: a robust model for quantitative comparison of ChIP-Seq data sets , 2011 .
[43] Avi Ma'ayan,et al. ChEA: transcription factor regulation inferred from integrating genome-wide ChIP-X experiments , 2010, Bioinform..
[44] Mariano J. Alvarez,et al. A human B-cell interactome identifies MYB and FOXM1 as master regulators of proliferation in germinal centers , 2010, Molecular systems biology.
[45] Donald Geman,et al. A Comprehensive Statistical Model for Cell Signaling , 2011, IEEE/ACM Transactions on Computational Biology and Bioinformatics.
[46] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[47] Xuerui Yang,et al. An Extensive MicroRNA-Mediated Network of RNA-RNA Interactions Regulates Established Oncogenic Pathways in Glioblastoma , 2011, Cell.
[48] Mingming Jia,et al. COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer , 2010, Nucleic Acids Res..
[49] Adam A. Margolin,et al. The Cancer Cell Line Encyclopedia enables predictive modeling of anticancer drug sensitivity , 2012, Nature.
[50] Data production leads,et al. An integrated encyclopedia of DNA elements in the human genome , 2012 .
[51] ENCODEConsortium,et al. An Integrated Encyclopedia of DNA Elements in the Human Genome , 2012, Nature.
[52] C. Roberts,et al. Molecular Pathways Molecular Pathways : SWI / SNF ( BAF ) Complexes Are Frequently Mutated in Cancer — Mechanisms and Potential Therapeutic Insights , 2013 .
[53] V. Kulasingam,et al. Quantitative mass spectrometry-based assay development and validation: from small molecules to proteins. , 2013, Clinical biochemistry.
[54] Andrea Califano,et al. Direct reversal of glucocorticoid resistance by AKT inhibition in acute lymphoblastic leukemia. , 2013, Cancer cell.
[55] Joshua C. Gilbert,et al. An Interactive Resource to Identify Cancer Genetic and Lineage Dependencies Targeted by Small Molecules , 2013, Cell.
[56] W. Hahn,et al. Prospective enterprise-level molecular genotyping of a cohort of cancer patients. , 2014, The Journal of molecular diagnostics : JMD.
[57] Mariano J. Alvarez,et al. Cross-species regulatory network analysis identifies a synergistic interaction between FOXM1 and CENPF that drives prostate cancer malignancy. , 2014, Cancer cell.
[58] J. Rodriguez,et al. Interplay between nuclear transport and ubiquitin/SUMO modifications in the regulation of cancer-related proteins. , 2014, Seminars in cancer biology.
[59] Andreas Krämer,et al. Causal analysis approaches in Ingenuity Pathway Analysis , 2013, Bioinform..
[60] Mariano J. Alvarez,et al. Identification of Causal Genetic Drivers of Human Disease through Systems-Level Analysis of Regulatory Networks , 2014, Cell.
[61] Anne E Carpenter,et al. ZFHX4 interacts with the NuRD core member CHD4 and regulates the glioblastoma tumor-initiating cell state. , 2014, Cell reports.
[62] R. Mazroui,et al. Control of mRNA turnover: implication of cytoplasmic RNA granules. , 2014, Seminars in cell & developmental biology.
[63] Mariano J. Alvarez,et al. Interrogation of a Context‐Specific Transcription Factor Network Identifies Novel Regulators of Pluripotency , 2015, Stem cells.